Some women using these injections have reported experiencing symptoms like irregular bleeding, changes in menstrual flow, and, in some cases, a temporary pause in menstruation
There are two exceptions that allow a provider to compound a GLP-1 drug: (1) if the drug is not commercially available, and (2) if the compounded drug includes a change, made for an identified individual patient, which produces for that patient a significant difference, as determined by the prescribing practitioner, between the compounded drug and the commercially available product. The identified change must be documented appropriately on the prescription or order
This level of clinical guidance, coupled with a strong behavior-change foundation, is how smart employers are addressing adherence issues, clinical outcomes, and chronic-condition costs
Lixisenatide (Lyxumia [EU], Adlyxin [US]): These agonists were developed for treating type II diabetes and have been shown to have neuroprotective effects and reduce inflammation
Due to semaglutide's long half-life and sustained action, the timing of administration relative to meals does not significantly impact its efficacy